Literature DB >> 11380101

Experimental hypercholesterolemia induces apoptosis in the aortic valve.

N M Rajamannan1, G Sangiorgi, M Springett, K Arnold, T Mohacsi, L G Spagnoli, W D Edwards, A J Tajik, R S Schwartz.   

Abstract

BACKGROUND AND AIM OF THE STUDY: Aortic valve disease is presently the number one indication for valve replacement in the United States, yet its molecular mechanisms remain unknown. As apoptosis (programmed cell death) occurs in degenerative disease states, it was postulated that experimental hypercholesterolemia is associated with apoptosis in rabbit aortic valves.
METHODS: New Zealand White rabbits (n = 8) were fed a 1% cholesterol diet for 12 weeks; control rabbits (n = 8) were fed a normal diet. After sacrifice of the animals, the aortic valves were dissected. Apoptosis was identified in the valvular lesion by TdT-mediated dUTP-biotin nick end-labeling (TUNEL) technique, and confirmed with transmission electron microscopy. The number of apoptotic cells was measured by computed morphometry.
RESULTS: Valves from hypercholesterolemic rabbits showed an increase in apoptosis. TUNEL staining was identified in the atherosclerotic layer of hypercholesterolemic valves (0.1% of cells), but not in the cells of controls (p <0.0001).
CONCLUSION: Apoptosis is increased in rabbit aortic valves during experimental hypercholesterolemia. If fatal cellular degeneration occurs in hypercholesterolemic valve disease, these data suggest that apoptosis may play a role in the mechanism of valvular disease.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11380101

Source DB:  PubMed          Journal:  J Heart Valve Dis        ISSN: 0966-8519


  26 in total

1.  Is it time for medical therapy for aortic valve disease?

Authors:  Nalini M Rajamannan
Journal:  Expert Rev Cardiovasc Ther       Date:  2004-11

2.  Calcific aortic stenosis: a disease ready for prime time.

Authors:  Nalini M Rajamannan
Journal:  Circulation       Date:  2006-11-07       Impact factor: 29.690

3.  Elevated cyclic stretch induces aortic valve calcification in a bone morphogenic protein-dependent manner.

Authors:  Kartik Balachandran; Philippe Sucosky; Hanjoong Jo; Ajit P Yoganathan
Journal:  Am J Pathol       Date:  2010-05-20       Impact factor: 4.307

Review 4.  Calcific aortic valve stenosis: methods, models, and mechanisms.

Authors:  Jordan D Miller; Robert M Weiss; Donald D Heistad
Journal:  Circ Res       Date:  2011-05-27       Impact factor: 17.367

5.  Aortic valve sclerosis in mice deficient in endothelial nitric oxide synthase.

Authors:  Ramzi N El Accaoui; Sarah T Gould; Georges P Hajj; Yi Chu; Melissa K Davis; Diane C Kraft; Donald D Lund; Robert M Brooks; Hardik Doshi; Kathy A Zimmerman; William Kutschke; Kristi S Anseth; Donald D Heistad; Robert M Weiss
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-03-07       Impact factor: 4.733

Review 6.  Visualizing novel concepts of cardiovascular calcification.

Authors:  Jesper Hjortnaes; Sophie E P New; Elena Aikawa
Journal:  Trends Cardiovasc Med       Date:  2013-01-03       Impact factor: 6.677

7.  Approach to the patient with bicuspid aortic valve and ascending aorta aneurysm.

Authors:  José T Ortiz; David D Shin; Nalini M Rajamannan
Journal:  Curr Treat Options Cardiovasc Med       Date:  2006-12

Review 8.  Myxomatous mitral valve disease bench to bedside: LDL-density-pressure regulates Lrp5.

Authors:  Nalini M Rajamannan
Journal:  Expert Rev Cardiovasc Ther       Date:  2014-03

Review 9.  Molecular mechanisms underlying the onset of degenerative aortic valve disease.

Authors:  Daihiko Hakuno; Naritaka Kimura; Masatoyo Yoshioka; Keiichi Fukuda
Journal:  J Mol Med (Berl)       Date:  2008-09-03       Impact factor: 4.599

10.  Smoothelin-positive cells in human and porcine semilunar valves.

Authors:  Massimo Cimini; Kem A Rogers; Derek R Boughner
Journal:  Histochem Cell Biol       Date:  2003-10-02       Impact factor: 4.304

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.